# Maintenance Treatment Versus Observation in Elderly Patients With PCNS Lymphoma

> **NCT02313389** · PHASE3 · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 428 (actual)

## Conditions studied

- Primary Central Nervous System Lymphoma

## Interventions

- **DRUG:** Rituximab, Methotrexate, Temozolomide

## Key facts

- **NCT ID:** NCT02313389
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2023-04
- **Final completion:** 2023-04
- **Target enrollment:** 428 (ACTUAL)
- **Last updated:** 2022-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02313389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02313389, "Maintenance Treatment Versus Observation in Elderly Patients With PCNS Lymphoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02313389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*